Please assess the completion status of the following clinical trial:

Trial Title: Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* 6-month history of migraine~* Migraine attacks typically mild when they begin with 1-4 migraine attacks per month~Exclusion Criteria:~* Heart disease~* High blood pressure

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).